(Q34637209)

English

Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study (English)

1 reference

Europe PubMed Central

3 August 2017

0 references

0 references

multiple myeloma

1 reference

based on heuristic

inferred from title

author name string

Terry Golombick

1

1 reference

Europe PubMed Central

3 August 2017

Terrence H Diamond

2

1 reference

Europe PubMed Central

3 August 2017

Arumugam Manoharan

3

1 reference

Europe PubMed Central

3 August 2017

Rajeev Ramakrishna

4

1 reference

Europe PubMed Central

3 August 2017

publication date

4 April 2012

1 reference

Europe PubMed Central

3 August 2017

American Journal of Hematology

1 reference

Europe PubMed Central

3 August 2017

87

1 reference

Europe PubMed Central

3 August 2017

5

1 reference

Europe PubMed Central

3 August 2017

455-460

1 reference

Europe PubMed Central

3 August 2017

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23159

21 January 2018

Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23159

21 January 2018

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23159

21 January 2018

Appraisal of immunoglobulin free light chain as a marker of response

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23159

21 January 2018

Prevention of progression in monoclonal gammopathy of undetermined significance

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23159

21 January 2018

Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23159

21 January 2018

Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23159

21 January 2018

The potential role of curcumin in patients with monoclonal gammopathy of undefined significance--its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover marker

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23159

21 January 2018

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23159

21 January 2018

Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23159

21 January 2018

Dose escalation of a curcuminoid formulation

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23159

21 January 2018

Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myeloma

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23159

21 January 2018

International uniform response criteria for multiple myeloma.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23159

21 January 2018

Serum free light chains for monitoring multiple myeloma.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23159

21 January 2018

Curcumin: the Indian solid gold

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23159

21 January 2018

Curcumin: getting back to the roots.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23159

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23159

21 January 2018

Effects of curcumin on the skeletal system in rats

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23159

21 January 2018

Identifiers

10.1002/AJH.23159

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34637209&oldid=1639513036"